Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Astec Industries
ASTE
$1.16B
| $14.9M | 0.01% |
237,141
+4,349
| +2% | +$304K |
|
1777
Liberty Global Class A
LBTYA
$3.62B
| $14.9M | ﹤0.01% |
546,835
+21,355
| +4% | +$576K |
|
|
GBT
1778
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.9M | ﹤0.01% |
424,055
+127,104
| +43% | +$4.96M |
|
1779
Upstart Holdings
UPST
$2.63B
| $14.8M | ﹤0.01% |
118,880
+33,896
| +40% | +$4.17M |
|
|
RWT
1780
Redwood Trust
RWT
$574M
| $14.8M | ﹤0.01% |
1,230,032
+2,715
| +0.2% | +$30.3K |
|
1781
Modine Manufacturing
MOD
$10.7B
| $14.8M | ﹤0.01% |
892,522
-82,274
| -8% | -$1.35M |
|
|
AVNS
1782
DELISTED
Avanos Medical
AVNS
| $14.8M | ﹤0.01% |
406,743
+9,483
| +2% | +$392K |
|
1783
Scansource
SCSC
$1.15B
| $14.8M | ﹤0.01% |
524,589
+35,129
| +7% | +$1.05M |
|
1784
Opko Health
OPK
$985M
| $14.7M | ﹤0.01% |
3,641,656
+26,314
| +0.7% | +$103K |
|
1785
Stride
LRN
$3.41B
| $14.7M | ﹤0.01% |
458,929
+23,117
| +5% | +$689K |
|
|
WLL
1786
DELISTED
Whiting Petroleum Corporation
WLL
| $14.7M | ﹤0.01% |
269,996
+85,209
| +46% | +$3.66M |
|
|
SCHR
1787
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $14.7M | ﹤0.01% |
+517,396
| New | +$14.7M |
|
1788
Park National Corp
PRK
$3.76B
| $14.6M | ﹤0.01% |
124,645
+1,689
| +1% | +$213K |
|
|
LGF.A
1789
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $14.6M | ﹤0.01% |
706,307
-5,911
| -0.8% | -$103K |
|
1790
Alamo Group
ALG
$1.94B
| $14.6M | ﹤0.01% |
95,406
+1,196
| +1% | +$186K |
|
|
HTO
1791
H2O America
HTO
$2.57B
| $14.6M | ﹤0.01% |
230,090
+15,635
| +7% | +$1.01M |
|
1792
Apogee Enterprises
APOG
$826M
| $14.6M | ﹤0.01% |
357,368
+1,393
| +0.4% | +$52.5K |
|
1793
Huazhu Hotels Group
HTHT
$13.1B
| $14.6M | ﹤0.01% |
275,559
+36,001
| +15% | +$2.03M |
|
|
DHC
1794
Diversified Healthcare Trust
DHC
$2.15B
| $14.5M | ﹤0.01% |
3,480,182
+73,242
| +2% | +$302K |
|
1795
Nelnet
NNI
$4.88B
| $14.5M | ﹤0.01% |
193,280
+3,196
| +2% | +$240K |
|
1796
Delek US
DK
$4.16B
| $14.5M | ﹤0.01% |
672,475
+92,912
| +16% | +$2.1M |
|
1797
Groupon
GRPN
$1.05B
| $14.5M | ﹤0.01% |
334,964
+2,573
| +0.8% | +$121K |
|
|
TBIO
1798
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $14.5M | ﹤0.01% |
524,805
-23,279
| -4% | -$457K |
|
1799
TAL Education Group
TAL
$6.93B
| $14.4M | ﹤0.01% |
572,649
+80,985
| +16% | +$3.62M |
|
|
BLUE
1800
DELISTED
bluebird bio
BLUE
| $14.4M | ﹤0.01% |
34,870
+11,063
| +46% | +$4.38M |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.